Products for Research Use Only
RegisterLogin

CDK12/13-IN-3

CAT: 0931-T206377-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T206377-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
3029608-57-6
Target
CDK
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
CDK12/13-IN-3 (Compound 12b) is an orally active CDK inhibitor targeting CDK12 and CDK13, with IC50 values of 107.4 nM and 79.4 nM, respectively. This compound inhibits the phosphorylation of Ser2 on the CTD of RNA polymerase II, induces DNA damage, and downregulates the gene expression involved in the DNA damage response (DDR) . CDK12/13-IN-3 exhibits antiproliferative effects against various cancer cells with nanomolar IC50 values. In mouse models, it demonstrates antitumor activity, favorable pharmacokinetic properties, and an oral bioavailability of 53.6%.
Smiles
C(C=C)(=O)N1CC=2C(=C(N=CN2)N3C[C@H](NC=4N=C(OC)C(Cl)=CN4)CC3)CC1
Molecular Formula
C19H22ClN7O2
Molecular Weight
415.877
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T205272-01CDK12/13-IN-2
T86026-01CDK12/13-IN-1
T201159-01CDK12/13 ligand 1
T64284-01PROTAC CDK12/13 Degrader-1
T14990-01CDK12-IN-3
T40289CDK12-IN-6
T40288CDK12-IN-4
T40290-01CDK12-IN-5
T207456-01CDK12-IN-8
T39752-01CDK12-IN-2

Alternative Products

CatalogName
HY-173059-01CDK12/13-IN-3
GTR19277078-01CDK12/13 ligand 3
HY-160284CDK12/13-IN-1
GTR19249505-01CDK12/13-IN-2
HY-168163CDK12/13 ligand 1
HY-168658CDK12/13 ligand 2
TBI4864-25MGSR-4835, CDK12/13 inhibitor
HY-151110-01PROTAC CDK12/13 Degrader-1
VND18450-01CDK12-IN-3
A23984-10PROTAC CDK12/13 Degrader-1 10mg

Popular Products